Sourcebio International PLC
LSE:SBI

Watchlist Manager
Sourcebio International PLC Logo
Sourcebio International PLC
LSE:SBI
Watchlist
Price: 115 GBX 4.55% Market Closed
Market Cap: 78.4m GBX

Sourcebio International PLC
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sourcebio International PLC
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Sourcebio International PLC
LSE:SBI
EPS (Diluted)
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kooth PLC
LSE:KOO
EPS (Diluted)
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genincode PLC
LSE:GENI
EPS (Diluted)
ÂŁ0
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PHSC PLC
LSE:PHSC
EPS (Diluted)
ÂŁ0
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Trellus Health PLC
LSE:TRLS
EPS (Diluted)
$0
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sourcebio International PLC
Glance View

Market Cap
85.3m GBX
Industry
Health Care

SourceBio International Plc engages in the provision of laboratory services in healthcare, clinical, life science research, and biopharma industries. The company is headquartered in Nottingham, Nottinghamshire. The company went IPO on 2020-10-29. The firm operates through four business segments: Infectious Disease Testing, Healthcare Diagnostics, Genomics and Stability Storage. Its Infectious Disease Testing segment offers COVID-19 antigen reverse transcription-polymerase chain reaction (RT-PCR) testing services to the national health service (NHS), private healthcare providers and private industry. Its Healthcare Diagnostics segment offers histopathology and clinical diagnostic services for the NHS and private healthcare across the United Kingdom and Ireland. Its Genomics segment offers deoxyribonucleic acid (DNA) sequencing services for pharmaceutical and biotechnology companies, academia, contract research organizations (CROs) and other research groups in the United Kingdom, Europe and North America. Its Stability Storage segment offers shelf-life testing services and equipment for pharmaceutical companies and others.

SBI Intrinsic Value
Not Available

See Also

What is Sourcebio International PLC's EPS (Diluted)?
EPS (Diluted)
0.2 GBP

Based on the financial report for Dec 31, 2021, Sourcebio International PLC's EPS (Diluted) amounts to 0.2 GBP.

What is Sourcebio International PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
475%

Over the last year, the EPS (Diluted) growth was 475%.

Back to Top